ArticleBMC cancer2020

Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial.

Nut Koonrungsesomboon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.